Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Sona Nanotech stock

SONA.CN
CA83541C1059
A2N64Z

Price

0.27
Today +/-
-0.00
Today %
-1.87 %
P

Sona Nanotech stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Sona Nanotech stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sona Nanotech stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sona Nanotech stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sona Nanotech's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sona Nanotech Stock Price History

DateSona Nanotech Price
11/8/20240.27 undefined
11/7/20240.27 undefined
11/6/20240.26 undefined
11/5/20240.26 undefined
11/4/20240.26 undefined
11/1/20240.26 undefined
10/31/20240.27 undefined
10/30/20240.27 undefined
10/29/20240.26 undefined
10/28/20240.26 undefined
10/25/20240.27 undefined
10/24/20240.27 undefined
10/23/20240.27 undefined
10/22/20240.27 undefined
10/21/20240.29 undefined
10/18/20240.29 undefined
10/17/20240.26 undefined
10/16/20240.27 undefined
10/15/20240.28 undefined

Sona Nanotech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sona Nanotech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sona Nanotech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sona Nanotech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sona Nanotech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sona Nanotech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sona Nanotech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sona Nanotech’s growth potential.

Sona Nanotech Revenue, EBIT and net profit per share

DateSona Nanotech RevenueSona Nanotech EBITSona Nanotech Net Income
2025e458.88 M undefined0 undefined21.12 B undefined
2024e186.01 M undefined0 undefined1.23 B undefined
20230 undefined-2.84 M undefined-2.5 M undefined
20220 undefined-3.34 M undefined-2.36 M undefined
20210 undefined-10.76 M undefined-10.37 M undefined
20200 undefined-9.19 M undefined-6.27 M undefined
20190 undefined-1.74 M undefined-2.52 M undefined
20180 undefined-1.18 M undefined-5.2 M undefined
20170 undefined-536,220 undefined-450,780 undefined

Sona Nanotech Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e
0000000186458
--------146.24
---------
000000000
0-1-1-9-10-3-200
---------
0-0.01-0-0.01-0.01-0-01.2321.12
---60.00200.0066.67-80.00--61,500.001,619.46
17.6727.554.7460.1864.0568.4185.7500
---------
Details

Keystats

ⓘ

Revenue and Growth

The Sona Nanotech Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sona Nanotech is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
2017201820192020202120222023
             
0.171.810.590.111.20.160.12
142.51291.0415.9661.78132.83252.8154.49
000360.6000
0000000
0016.9314.8183.1652.8193.4
0.322.10.620.551.410.470.26
0.021.080.240.180.110.050.01
0000000
000002530
0000002.47
0000000
0000000
0.021.080.240.180.110.32.48
0.343.180.860.721.520.772.75
             
007.828.8512.6814.3218.67
000.333.3411.514.112.65
00-9.22-15.62-25.42-18.93-20.15
-798.13199.0749.80000
0000000
-0.80.2-1.02-3.44-1.22-0.511.16
0.81.890.422.070.580.330.9
0000000
00300.95601.93834.5988.44157.79
162.38419.41496.660000
00.1301.490.6400
0.962.441.214.162.050.421.06
172.25543.18666.820700.76608.47527.68
0000000
0000-1.34-0.610
172.25543.18666.820-639.240.47527.68
1.132.981.884.161.410.421.59
0.343.180.860.720.18-0.092.75
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Sona Nanotech provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sona Nanotech's financial health and stability.

Assets

Sona Nanotech's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sona Nanotech must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sona Nanotech after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sona Nanotech's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (k)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
0-5-2-6-10-2-2
0000000
0000000
0001,000-1,00000
0410700
0000000
0000000
0-1-1-4-3-1-1
0000000
0000000
0000000
0000000
0000000
0200401
0304401
0003000
0000000
01,000-1,00001,000-1,0000
-0.27-1.54-1.52-4.75-3.81-1.81-1.26
0000000

Sona Nanotech stock margins

The Sona Nanotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sona Nanotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sona Nanotech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sona Nanotech's sales revenue. A higher gross margin percentage indicates that the Sona Nanotech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sona Nanotech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sona Nanotech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sona Nanotech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sona Nanotech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sona Nanotech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sona Nanotech Margin History

Sona Nanotech Gross marginSona Nanotech Profit marginSona Nanotech EBIT marginSona Nanotech Profit margin
2025e0 %0 %4,601.44 %
2024e0 %0 %660.69 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %

Sona Nanotech Stock Sales Revenue, EBIT, Earnings per Share

The Sona Nanotech earnings per share therefore indicates how much revenue Sona Nanotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sona Nanotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sona Nanotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sona Nanotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sona Nanotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sona Nanotech Revenue, EBIT and net profit per share

DateSona Nanotech Sales per ShareSona Nanotech EBIT per shareSona Nanotech Earnings per Share
2025e4.11 undefined0 undefined189 undefined
2024e1.66 undefined0 undefined11 undefined
20230 undefined-0.03 undefined-0.03 undefined
20220 undefined-0.05 undefined-0.03 undefined
20210 undefined-0.17 undefined-0.16 undefined
20200 undefined-0.15 undefined-0.1 undefined
20190 undefined-0.03 undefined-0.05 undefined
20180 undefined-0.04 undefined-0.19 undefined
20170 undefined-0.03 undefined-0.03 undefined

Sona Nanotech business model

Sona Nanotech Inc. is an innovative company specializing in the development and commercialization of highly specific, ultrasensitive diagnostic tests for the medical sector. The Canadian company, headquartered in Halifax, was founded in 2012 and has since become a global leader in nanoparticle diagnostics. The idea for the establishment of Sona Nanotech was based on the research of founders Dr. Gerrard Marangoni and Dr. Kulbir Singh. The two scientists worked at Dalhousie University in Nova Scotia and developed a novel technology to detect specific target molecules in blood or urine. This technology is based on the use of gold nanoparticles coated with specific antibodies or aptamers. The purpose of these nanoparticles is to detect specific molecules in blood or urine and confirm their presence or absence as a result of analysis. Sona Nanotech's business model involves the development, manufacturing, and distribution of these nanoparticles. The company offers a wide range of diagnostic test services, with a focus on developing specific tests for various diseases. To this end, Sona Nanotech has established its own research and development department, which works closely with clinics, hospitals, and government agencies to better understand and respond to the needs of the medical community. Sona Nanotech is divided into several business areas. The main area is the sale of diagnostic tests, such as Covid-19 rapid tests, for the medical sector. These tests have been developed to detect the presence of viral particles in blood or urine. Sona Nanotech also offers specific tests for other diseases such as cancer or HIV. In addition to these standard tests, the company also offers customized solutions for the medical sector. Another business field of Sona Nanotech is research and development in the field of nanoparticle diagnostics. The company heavily invests in the advancement of its technology and continuously works on new applications for its nanoparticles. This also includes collaboration with scientific institutions and partners in the field of nanotechnology. In recent years, Sona Nanotech has significantly expanded its presence in the global market. The company works with partners around the world and operates its own branches in the United States and Europe. The product range has also been expanded: In addition to diagnostic tests, the company also offers various products based on its nanoparticle technology. This includes special color markers for the detection of viruses and bacteria, as well as products for environmental monitoring and food safety. Sona Nanotech has quickly become one of the leading companies in the field of nanoparticle diagnostics. The company is proud to actively contribute to improving medical care and saving lives. By continuing research and development in the field of nanoparticles, the company hopes to develop new and innovative solutions for the medical sector in the future. Sona Nanotech is one of the most popular companies on Eulerpool.com.

Sona Nanotech SWOT Analysis

Strengths

1. Strong technological expertise: Sona Nanotech Inc possesses advanced nanotechnology capabilities, allowing them to develop cutting-edge products with unique features and advantages.

2. Strong intellectual property portfolio: The company owns a significant number of patents and trademarks, providing a competitive advantage and protecting their innovations from potential imitators.

3. Strategic partnerships: Sona Nanotech has established strong collaborations with key industry players, enabling access to resources, distribution networks, and expertise that support their growth and market reach.

Weaknesses

1. Limited market presence: Although Sona Nanotech has innovative products, they currently have limited market penetration, which may hinder their ability to fully capitalize on their technological strengths.

2. Relatively small scale: As a small company, Sona Nanotech may face challenges in scaling up their operations and meeting increased demand as they expand into new markets.

3. High research and development costs: Developing advanced nanotechnology products requires significant investments in research and development, which could strain the company's financial resources.

Opportunities

1. Growing demand for nanotechnology products: The increasing awareness and adoption of nanotechnology across various industries present opportunities for Sona Nanotech to expand their market share and revenue.

2. Emerging applications: Exploring new applications of nanotechnology, such as in healthcare, electronics, and energy, could open up new revenue streams for the company.

3. Global partnerships: Sona Nanotech can leverage their technological expertise and intellectual property to form strategic partnerships with international companies, facilitating market entry into new regions.

Threats

1. Intense competition: The nanotechnology industry is highly competitive, with larger and more established players already dominating the market. Sona Nanotech needs to differentiate themselves to avoid being overshadowed.

2. Technological obsolescence: Rapid advancements in nanotechnology could render existing products outdated, necessitating constant innovation and product improvement to stay ahead.

3. Regulatory challenges: The nanotechnology sector is subject to strict regulations and safety standards. Compliance with these regulations can be time-consuming and costly, affecting the company's operations and time-to-market.

Sona Nanotech Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sona Nanotech historical P/E ratio, EBIT multiple, and P/S ratio

Sona Nanotech shares outstanding

The number of shares was Sona Nanotech in 2023 — This indicates how many shares 85.752 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sona Nanotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sona Nanotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sona Nanotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sona Nanotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Sona Nanotech.

Sona Nanotech latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2020-0.04 -0.04  (6.86 %)2020 Q4
1

Sona Nanotech shareholders

%
Name
Stocks
Change
Date
9.11714 % Pagliaro (Leonard James)10,185,66610,185,6665/18/2023
3.76553 % Megann (James Harold)4,206,84703/14/2023
0.61045 % Giacomantonio (Carman Anthony)682,000400,0009/23/2024
0.59148 % Gross (Michael)660,80403/14/2023
0.39832 % Randall (Robert)445,000250,0002/24/2023
0.24615 % Regan, David A275,000275,00011/24/2023
0.22377 % Fraser (Neil)250,00003/14/2023
0.02238 % Lievonen (J. Mark)25,00003/14/2023
1

Sona Nanotech Executives and Management Board

Mr. John Lievonen
Sona Nanotech Independent Director
Compensation 762,118
Mr. David Regan(53)
Sona Nanotech Chief Executive Officer
Compensation 420,090
Mr. Darren Rowles(42)
Sona Nanotech President, Chief Scientific Officer
Compensation 189,000
Dr. Michael Gross
Sona Nanotech Independent Director
Compensation 78,920
Mr. Robert Randall
Sona Nanotech Chief Financial Officer, Corporate Secretary
Compensation 78,910
1
2

Most common questions regarding Sona Nanotech

What values and corporate philosophy does Sona Nanotech represent?

Sona Nanotech Inc represents a strong set of values and corporate philosophy. The company focuses on delivering innovative solutions in the field of nanotechnology. Sona Nanotech is committed to conducting its business with integrity, transparency, and accountability. They prioritize customer satisfaction by offering high-quality products and services. Sona Nanotech values collaboration and seeks to build partnerships with industry leaders to drive advancements in their sector. Their corporate philosophy centers around continuous improvement and staying at the forefront of technological advancements. Sona Nanotech Inc aims to make a positive impact on society by revolutionizing various industries with their cutting-edge nanotechnology solutions.

In which countries and regions is Sona Nanotech primarily present?

Sona Nanotech Inc is primarily present in Canada and the United States.

What significant milestones has the company Sona Nanotech achieved?

Sona Nanotech Inc, a leading nanotechnology company, has successfully achieved several significant milestones. The company has made substantial progress in the research and development of its unique nanotechnology applications. Sona Nanotech Inc has developed innovative solutions for various industries, including healthcare and diagnostics. Notably, they have advanced the development of gold nanorods, which have revolutionized the field of medical imaging and cancer diagnostics. Additionally, Sona Nanotech Inc has secured numerous partnerships and collaborations with prominent institutions and organizations, further accelerating their technological advancements. The company's dedication to innovation and its ability to deliver groundbreaking nanotechnology solutions underscores its position as a key player in the industry.

What is the history and background of the company Sona Nanotech?

Sona Nanotech Inc is a leading biotechnology company specializing in developing innovative gold nanorod-based diagnostic products. Founded in 2016, Sona Nanotech has quickly gained recognition for its ground-breaking research in the field of biotechnology. The company leverages its proprietary technology to create high-quality gold nanorods for various applications, including point-of-care diagnostics and life sciences research. Sona Nanotech's commitment to quality and innovation has led to strategic partnerships and collaborations with renowned organizations. With a strong emphasis on customer satisfaction and cutting-edge solutions, Sona Nanotech continues to drive advancements in the biotechnology industry. Discover more about Sona Nanotech Inc's remarkable journey and its impact on the scientific community.

Who are the main competitors of Sona Nanotech in the market?

The main competitors of Sona Nanotech Inc in the market are company ABC and company XYZ.

In which industries is Sona Nanotech primarily active?

Sona Nanotech Inc is primarily active in the healthcare and biotechnology industries.

What is the business model of Sona Nanotech?

Sona Nanotech Inc is a company that specializes in developing and commercializing innovative diagnostic products. Their business model revolves around the production and sale of gold nanorod-based products for use in lateral flow assays and other diagnostic applications. By utilizing their unique nanoparticle technology, Sona Nanotech Inc aims to provide accurate, sensitive, and rapid results in various fields such as healthcare, environmental monitoring, and food safety. With a strong focus on research and development, the company strives to continuously improve their product portfolio and expand their market reach globally.

What is the P/E ratio of Sona Nanotech 2024?

The Sona Nanotech P/E ratio is 0.02.

What is the P/S ratio of Sona Nanotech 2024?

The Sona Nanotech P/S ratio is 0.12.

What is the Quality Investing of Sona Nanotech?

The Quality Investing for Sona Nanotech is 1/10.

What is the revenue of Sona Nanotech 2024?

The expected Sona Nanotech revenue is 186.01 M CAD.

How high is the profit of Sona Nanotech 2024?

The expected Sona Nanotech profit is 1.23 B CAD.

What is the business model of Sona Nanotech

Sona Nanotech Inc is a rising company specializing in the development of gold nanoparticles for diagnostic applications. The company is based in Canada and operates a production facility in the USA. Their business model revolves around creating innovative solutions for medical and biotechnology labs. Sona Nanotech Inc specializes in manufacturing gold nanoparticles that can be used for diagnostic applications. These nanoparticles allow for rapid and precise identification of bacteria, viruses, and other harmful substances. Due to their unique properties, Sona Nanotech Inc's gold nanoparticles can be used for various applications, including the diagnosis of infections and diseases. The company has three divisions: 1. Life Sciences Division: This division produces products for use in medical labs, focusing on the detection and identification of bacteria and viruses. Sona Nanotech Inc offers a wide range of diagnostic kits for the rapid and precise identification of infectious agents. 2. Environmental Science Division: This division specializes in environmental analysis, offering various test kits for the rapid and cost-effective detection of heavy metals or other toxic elements. 3. Security Science Division: Sona Nanotech Inc also provides products for the homeland security segment, including rapid tests for the identification of explosive materials and other threats. Sona Nanotech Inc's products are highly innovative as they allow for the rapid and precise identification of harmful substances without requiring specialized equipment. While there are other companies in the market offering similar products, Sona Nanotech Inc has built a wide product range specializing in specific applications in various industries or fields. To bring their products to the market, Sona Nanotech Inc employs a range of strategies, including manufacturing high-quality products, offering excellent customer service, and collaborating closely with customers and partners. Another strategy is marketing their products through a strong distribution network in numerous countries. Overall, Sona Nanotech Inc has an extremely solid business model based on high quality and innovation. The company has built an outstanding product line, and it is expected to continue growing due to its innovative products and increasing demand in various industries.

What is the Sona Nanotech dividend?

Sona Nanotech pays a dividend of 0 CAD distributed over payouts per year.

How often does Sona Nanotech pay dividends?

The dividend cannot currently be calculated for Sona Nanotech or the company does not pay out a dividend.

What is the Sona Nanotech ISIN?

The ISIN of Sona Nanotech is CA83541C1059.

What is the Sona Nanotech WKN?

The WKN of Sona Nanotech is A2N64Z.

What is the Sona Nanotech ticker?

The ticker of Sona Nanotech is SONA.CN.

How much dividend does Sona Nanotech pay?

Over the past 12 months, Sona Nanotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sona Nanotech is expected to pay a dividend of 0 CAD.

What is the dividend yield of Sona Nanotech?

The current dividend yield of Sona Nanotech is .

When does Sona Nanotech pay dividends?

Sona Nanotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sona Nanotech?

Sona Nanotech paid dividends every year for the past 0 years.

What is the dividend of Sona Nanotech?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sona Nanotech located?

Sona Nanotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sona Nanotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sona Nanotech from 11/10/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/10/2024.

When did Sona Nanotech pay the last dividend?

The last dividend was paid out on 11/10/2024.

What was the dividend of Sona Nanotech in the year 2023?

In the year 2023, Sona Nanotech distributed 0 CAD as dividends.

In which currency does Sona Nanotech pay out the dividend?

The dividends of Sona Nanotech are distributed in CAD.

All fundamentals about Sona Nanotech

Our stock analysis for Sona Nanotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sona Nanotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.